Lichenysin-like Polypeptide Production by Bacillus licheniformis B3-15 and Its Antiadhesive and Antibiofilm Properties

We report the ability of the crude biosurfactant (BS B3-15), produced by the marine, thermotolerant Bacillus licheniformis B3-15, to hinder the adhesion and biofilm formation of Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213 to polystyrene and human cells. First, we attempted to increase the BS yield, optimizing the culture conditions, and evaluated the surface-active properties of cell-free supernatants. Under phosphate deprivation (0.06 mM) and 5% saccharose, the yield of BS (1.5 g/L) increased by 37%, which could be explained by the earlier (12 h) increase in lchAA expression compared to the non-optimized condition (48 h). Without exerting any anti-bacterial activity, BS (300 µg/mL) prevented the adhesion of P. aeruginosa and S. aureus to polystyrene (47% and 36%, respectively) and disrupted the preformed biofilms, being more efficient against S. aureus (47%) than P. aeruginosa (26%). When added to human cells, the BS reduced the adhesion of P. aeruginosa and S. aureus (10× and 100,000× CFU/mL, respectively) without altering the epithelial cells’ viability. As it is not cytotoxic, BS B3-15 could be useful to prevent or remove bacterial biofilms in several medical and non-medical applications.


Introduction
Surface-active molecules (SAMs) are produced by a large variety of microorganisms to increase the bioavailability of hydrophobic compounds as potential carbon and energy sources [1]. Bacterial SAMs can be distinguished into two different classes according to their molecular weight: biosurfactants (BSs) and bioemulsifiers (BEs). BSs, including lipopeptides, glycolipids, and phospholipids, are compounds characterized by low molecular weight and efficiently reduce both surface and interfacial tension [2][3][4]. Unlike BSs, BEs are able to efficiently emulsify hydrophobic substrates, and they have higher molecular weight, since they are constituted by a mixture of biopolymers (such as polysaccharides, lipopolysaccharides, lipoproteins, and proteins) [4][5][6]. Due to the marked differences of the lichenysin synthetase A gene (lchAA) at different times of bacterial growth (12 h, 24 h, and 48 h). To evaluate the effects of P. aeruginosa and S. aureus on biofilm formation, crude BS B3-15 was added to polystyrene surfaces at different times, corresponding to the different phases of biofilm formation (i.e., initial attachment, reversible attachment, irreversible attachment) and after the biofilm was established. In order to address the BS B3-15 use in different medical and non-medical applications, the effects of the crude BS were evaluated on the adhesion of P. aeruginosa and S. aureus to human nasal epithelial cells, constituting the first targets of air-mediated bacterial infections.

Bacillus licheniformis Strain B3-15
The Bacillus licheniformis strain B3-15 has been previously reported as capable of producing BS B3-15 [45]. Briefly, strain B3-15 was isolated from thermal water emitted from a shallow hydrothermal vent near the Vulcano-Island Porto di Levante (Aeolian Islands, Italy), characterized by a depth of 5 m, and from temperature and pH water of 65 • C and 5.2, respectively [45]. The strain grew aerobically, with the lower-limit temperature of 25 • C and the upper-limit temperature of 60 • C. The pH range for growth was 5.5-9, with an optimal value of 7, and the strain grew in NaCl concentration ranging from 0 to 7% (w/v), with the optimum occurring at 2% (w/v). Furthermore, a partial 16S rRNA gene of the strain was sequenced, and the following accession number was assigned KC485000. To maintain the strain, B3-15 Tryptic Soy Agar (TSA, Sigma Aldrich, Burlington, MA, USA) plates, supplemented with 1% NaCl (1.5% NaCl final concentration), were used. The BS B3-15 was produced in Marine Broth supplemented with 3% of saccharose, and, after acid precipitation, its yield was 910 mg/L. The BS B3-15 was spectroscopically characterized as a surfactin-like lipopeptide.

Optimization of Culture Conditions for BS B3-15 Production
To evaluate the effects of the saccharose or glucose and phosphate content on the strain growth and BS production, the strain B3-15 (OD 600nm = 0.1, corresponding to 1.7 × 10 8 CFU/mL, as experimentally evaluated) was inoculated in the novel medium, named MGV, containing different concentrations of saccharose or glucose (0, 3, 5, 7% w/v), and K 2 HPO 4 (0.008-8 g/L) and KH 2 PO 4 (0.002-2 g/L) and incubated at optimal growth temperature of 45 • C for 48 h on rotating shakers (250 rpm) ( Table 1). The cell-free supernatant (CFS) was obtained using centrifugation at 8000 rpm for 10 min and filtration through a 0.2 µm pore size membrane (Biogenerica, Catania, Italy) of the culture. Aliquot (100 µL) of the filtrated supernatant was placed onto plates of TSA and incubated at a temperature of 45 • C for 24 h to verify that no bacterial cells were present. The CFSs were used for surface property assays. The CFS's surface-active properties were evaluated through the oil's drop-collapse and emulsification assays. To perform the oil's drop-collapse assay, a drop (100 µL) of each CFS was spotted on the polystyrene lid of a 96-microwell plate (Thermo-Fisher, Milan, Italy), and then mineral oil (5 µL) (Sigma Aldrich) was added. The CFS containing BS gave a flat drop.
The emulsification assay of each CFS was carried out as described by Tuleva et al. [46]. Briefly, each CFS or uninoculated sterile medium, used as negative controls, was mixed in a glass tube (10 cm high and 1 cm in diameter) with an equal volume of kerosene (Sigma Aldrich), vortexed vigorously, and left to stand for 24 h. The tubes were incubated at room temperature for 24 h, and the emulsion index was calculated according to the following formula: High of emulsion High of the whole solution × 100

Response Surface Methodology
The effect of the carbohydrate content (0-7%) and the phosphate (K 2 HPO 4 and KH 2 PO 4 ) concentration (from 0.06 to 60 mM) in the phosphate buffer on the overall biosurfactant production (evaluated by E 24 of CFS) was analyzed in a set of 13 experiments using the Response Surface Methodology-the Central Composite Design (RSM-CCD) tool of Minitab (version 21.0) statistical software. The interaction was expressed as the quadratic model equation to predict the optimized composition medium named MGV-op.

BS B3-15 Extraction
To extract the BS, each CFS was acidified at pH 2.0 using 2N HCl and kept overnight to allow precipitation [42,47]. An equal volume of a chloroform: methanol (2: 1 v/v) mixture was added to the acidified CFS, and the organic layer (extract) was separated from the aqueous phase (solvent). The BS dissolved in the organic phase was recovered using a rotary vapor treatment (Rotavapor ® R-300, BUCHI Italia S.r.l, Cornaredo, Italy) and a desiccation process (45 • C, overnight). The obtained BSs were finally weighed and stored at 4 • C.

Characterization of BS B3-15 using ATR-FTIR
To identify the functional groups of the crude BS, which was obtained under optimized conditions, the attenuated total reflectance Fourier Transform Infrared (ATR-FTIR) technique was used. VERTEX 70v FT-IR Spectrometer (Bruker Optics GmbH & Co. KG, Ettlingen, Germany) equipped with the platinum diamond was employed to obtain the spectra in the wavenumber range of 4000 to 400 cm −1 with a resolution of 4 cm −1 . Finally, OMNIC software version 7.3 (Origin Lab Co., Northampton, MA, USA) was employed to analyze the peaks of the BS spectrum.

BS B3-15 Surface-Active Properties
To assess the ability of the crude BS B3-15 to modify the hydrophobic surfaces at increasing concentrations (from 0 to 1600 µg/mL), the contact angle (θ) in the water solution was measured using the sessile-drop technique. Briefly, 5 µL of each BS B3-15 solution were spotted onto a lid of a 96-well microtiter plate (Thermo Fisher Scientific, Waltham, MA, USA), incubated at room temperature for 15 min, and photographed with a high-resolution camera, as previously reported [48]. To measure the angle (θ) on the sessile drop images, the images were analyzed (in triplicate) using the software ImageJ 1.54d (ImageJ, National Institutes of Health, Bethesda, MD, USA). Drop Snake plugin, and the average value and standard deviation were calculated.   (12, 24, and 48 h) and centrifuged at 8000 rpm × 10 min. To obtain RNAs, the cells were treated with Trizol Reagent (Life Technologies, Carlsbad, CA, USA). To remove the traces of DNA, the samples were treated for 30 min at 37 • C with 1 U of RNase-free DNase (Promega Corporation, Madison, WI, USA). An RQ1 DNase stop solution (1 µL) was used to stop the reaction, and the sample was incubated at 65 • C for 10 min. A total of 1 µg of RNA, spectrophotometrically quantized, was used for the reverse transcription of complementary DNA (cDNA). An equal amount of RNA for each sample was reverse-transcribed into cDNA using Improm II reverse transcriptase (RT) (Promega Corporation, USA). The RT reaction was carried out at 25 • C for 5 min, then at 37 • C for 60 min and 70 • C for 15 min.

Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
To evaluate the gene expression of bacterial cells in the different conditions, the qRT-PCR was performed as reported previously [50] using a 7500 Fast Real-Time PCR System. The reaction was carried out with the Sso Advanced universal SYBR1 Green supermix (BioRad, Laboratories, Heracles, CA, USA), and the following operating conditions were selected: 3 min at 95 • C, followed by 35 cycles of 15 s at 95 • C and 45 s at the suitable melting temperatures for each primer, as reported in Table 2. Each sample was tested in triplicate, and data are expressed using the 2 −∆∆Ct (Ct) method. The differences in the expression were indicated as fold changes with respect to MGV and normalized to the levels of the elongation factor-Tu. The strains used in this study (Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213) were acquired from the American Type Culture Collection (LGC Promochem, Teddington, UK). The P. aeruginosa was maintained in Luria Bertani broth (LB, Sigma Aldrich) and LB agarized with 2% Bacto agar (Difco, Baltimore, MD, USA), whereas, to maintain the S. aureus, Tryptic Soy Broth or Tryptic Soy Agar (TSB, TSA) was used.

Antibiofilm Activity of BS B3-15 on Polystyrene Surfaces at Increasing Concentrations
To assess the effect of the BS B3-15 on the biofilm formation of P. aeruginosa and S. aureus in 96-well polystyrene microplates (Thermo-Fisher Scientific, Milan, Italy), the assay previously reported by O'Toole et al. [51] was performed. Each well of the microplate (six replicates) was filled with 180 µL of P. aeruginosa or S. aureus culture (OD 600nm = 0.1), grown overnight in LB or TSB, respectively. BS B3-15 (20 µL) at the final concentrations of 50, 100, 200 or 300 µg/mL was added to each well, and Phosphate Buffer Saline (sPBS, Sigma Aldrich) was used as control.
2.5.3. Antibiofilm Activity Assay on Polystyrene Surfaces of BS B3-15 at Different Times BS B3-15's ability to hinder the P. aeruginosa and S. aureus biofilm formation was evaluated as previously reported [50]. Briefly, an aliquot (20 µL) of the BS B3-15 solution (300 µg/mL) or PBS (used as control) was added to each well, containing 180 µL of each culture as reported above, at different times of bacterial growth (0, 2, 4, 8, and 24 or 48 h). The BS B3-15 was added at different times corresponding to the phases of adhesion (0), reversible attachment (2 h), irreversible attachment (4 and 8 h), and mature biofilm (48 h for P. aeruginosa or 24 h for S. aureus) of the pathogenic strains. After incubation at 37 • C for 48 h (for P. aeruginosa) or 24 h (for S. aureus) in a static condition, the cultures were gently taken from each well; to remove non-adherent bacteria, each well was washed with distilled water three times, and biofilms were stained with 0.1% (w/v) crystal violet solution and incubated at room temperature for 20 min. To eliminate the excess stain, the plates were washed with distilled water (5 times) and air-dried (for 45 min). Aliquots (200 µL) of absolute ethanol were added to each well to dissolve crystal violet from the stained biofilm. The biofilm mass was determined using the absorbance (OD 585 nm ) of the de-staining solution measured using a microtiter plate reader (Multiskan GO, Thermo Scientific, Waltham, MA, USA). The reduction in biofilm formation was expressed by applying the following formula: Reduction in biofilm formation (%) = (OD (585 nm control) − OD (585 nm sample) )/OD (585 nm control) × 100 Each data point was averaged from six replicated microwells, and the standard deviation (SD) was calculated. Statistical significance (** p ≤ 0.01 or * p ≤ 0.05) was determined using one-way ANOVA.
The multicellular structures of the biofilms onto the polystyrene surface, not treated or treated with the BS B3-15, were observed using confocal Laser Scanning Microscopy, with the TCS SP2 microscope (Leica Microsystems Heidemberg, Mannheim, Germany), equipped with Ar/Kr laser, and coupled to a microscope (Leica DMIRB). Sterile polystyrene strips (0.5 cm × 1 cm) were placed into each well of 96-well microplates containing 180 µL of overnight cultures (OD 600nm = 0.1) of P. aeruginosa in LB or S. aureus in TSB and BS (20 µL) at a final concentration of 300 µg/mL or sterile PBS (used as control). The microplates were incubated at 37 • C for 24 h (for S. aureus) or 48 h (for P. aeruginosa). The strips were removed from the wells and washed five times with sterile PBS to take out non-adherent bacteria; then, SYTO9 (20 µg/mL) (LIVE/DEAD Bac-light Thermo Fisher Scientific) was added to each strip to stain adherent cells, and after dark incubation (30 • C for 5 min), the biofilm on the strips was observed. The 3D images were elaborated using COMSTAT ImageJ software1.54d [52].

BS B3-15 Antibacterial Activity
To determine the minimum inhibitory concentration (MIC) values of the BS, the serial dilution assay was carried out in microplates as previously reported [53]. Briefly, the BS B3-15 was serially diluted (1000, 500, 400, 300, 200, and 100 µg/mL) in Mueller Hinton Broth (MHB, Sigma-Aldrich, Milan, Italy) using microplates. After that, each well, containing different concentrations of BS B3-15, was inoculated with suitable aliquots of each strain suspension (OD 600nm = 0.1) in MHB. The microplates were placed at 37 • C overnight, and the growth of the strain was evaluated by measuring the optical absorbance (OD 600nm ).
The inhibitory activity of BS B3-15 was confirmed by inoculating suitable aliquots (100 µL) from each well without visible growth onto LB or TSA plates for P. aeruginosa and S. aureus, respectively, and incubating them overnight at 37 • C.
To evaluate the antibacterial activity, the standard disk diffusion method (Kirby Bauer test) was used as reported by the National Committee for Clinical Laboratory Standard (NCCLS 2000). Suspensions (OD 600nm = 0.1) of each strain were prepared in 3 mL of 0.9%NaCl from an overnight culture in LA or TSA, and aliquots of each suspension (100 µL) were inoculated onto triplicate plates of Mueller Hinton agar (Sigma-Aldrich, Milan, Italy). Sterile filter paper disks (6 mm in diameter, Oxoid) loaded with 300 µg of BS B3-15 were placed onto inoculated plates and incubated overnight at 37 • C. The size of the complete inhibition zone of each disk was determined, and the mean and standard deviation (n = 3) were calculated.

Bioluminescence Inhibition Assay
A bioluminescence inhibition assay was used to evaluate the potential interference of BS B3-15 in the bacterial quorum-sensing mechanism involved in the biofilm formation. Moreover, the test was used to detect the BS's toxic effects. Briefly, 20 mL of the standard medium Sea Water Complete (tryptone 5 g/L, yeast extract 3 g/L, glycerol 3 mL/L, 750 mL/L of seawater, and 250 mL/L of distilled water) in a flask was inoculated with Vibrio harveyi strain G5 and incubated at 28 • C overnight. Each well of a 96-well microtiter plate was filled with aliquots (80 µL) of the V. harveyi overnight culture (OD 600nm = 0.5, equivalent to 5 × 10 8 bacteria/mL). An aliquot (20 µL) of BS B3-15 solution, dissolved in 2%NaCl, or sterile 2%NaCl solution as control, was added to each well to reach a final BS concentration ranging from 125 to 1000 µg/mL. After 15 min of incubation at 25 • C, the luminescence of the bacterial cell suspension was evaluated and expressed as the relative luminescence unit (RLU), calculated as follows: RLU = luminescence/OD 600nm . The Effective Concentration (EC 50 ), as 50% of the RLU reduction, was used to indicate the BS's toxicity relative to the control.
2.6. Antibiofilm Activity Assay on Human Nasal Epithelial Cells of BS B3-15 2.6.1. Human Nasal Epithelial Cells Culture The Human Nasal Epithelial Cells (HNEpC) were obtained from the PromoCell (Cat. Num. C-12620, Heidelberg, Germany). HNEpC was cultured in RPMI 1640 (Invitrogen Cergy Pontoise, France), complemented with penicillin/streptomycin/amphotericin (Sigma Aldrich, Saint Louis, MO, USA) and 10% Fetal Bovine Serum (Sigma Aldrich, USA origin), in a 75 cm 2 flask and placed in the incubator at 37 • C with 5% CO 2 [54]. To form confluent monolayers, cells from cell monolayers treated with 5 mL Trypsin EDTA (Euroclone, Milan, Italy) were resuspended at a concentration of 2.5 × 10 5 cells/mL in culture medium and poured into each of the 96-well cell culture plates and incubated at suitable conditions.

Antibiofilm Activity Assay on Human Nasal Epithelial Cells of BS B3-15 with Increasing Concentrations of BS B3-15
To evaluate the effect of BS B3-15 on the adhesion of P. aeruginosa and S. aureus to HNEpC, the procedure proposed by Fernandes de Oliveira [55] was used. The RPMI was removed through careful aspiration, and HNEpC was washed three times with RPMI 1640 deprived of antibiotics and serum (RPMI-1). To infect the human cells, suspensions (100 µL) in RPMI-1 of P. aeruginosa or S. aureus (1 × 10 6 CFU/mL) were added to each well. BS, dissolved in RPMI-1 at different final concentrations (from 50 to 300 µg/mL), or RPMI-1, used as control, was added to HNEpC, and the microplates were incubated for 2 h (37 • C, 5% of CO 2 ). The cells were washed with RPMI-1 (two times) and PBS (one time) to remove the non-adherent bacterial cells. After that, cold, distilled, sterile water (100 µL) was poured into each well to induce the lysis of the HNEpC, and non-adherent bacterial cells were recovered. The suspensions of non-adherent bacterial cells were serially diluted ten-fold in PBS and plated onto cetrimide agar (Oxoid) for P. aeruginosa or onto mannitol salt agar (Oxoid) for S. aureus. The plates were incubated at 37 • C for 18-24 h, and the Colony-Forming Units (CFUs) were counted.

Statistical Analysis
Averages and standard deviations (SDs) were calculated in all the experiments (in triplicate). Statistically significant differences among the groups were calculated using two-way ANOVA followed by Tukey's multiple comparisons tests (** p ≤ 0.01, * p ≤ 0.05) using GraphPad Prism (version 9.0; GraphPad Software, San Diego, CA, USA).

Optimization of Culture Conditions for BS B3-15 Production
The effects of glucose (GLU) or saccharose (SAC) at different concentrations (from 0 to 7%, w/v) in the MGV medium on the growth and biosurfactant production, estimated as the emulsifying index (E 24 ) of Bacillus licheniformis B3-15 (BS B3-15), are shown in Table 3. The presence of GLU or SAC at 5% showed the highest values of bacterial growth (OD 600nm = 6) after 48 h incubation at 45 • C. However, the CFS obtained with SAC 5% was surface-active (oil drop-collapse assay) and exhibited the highest emulsifying activity (E 24 = 60%).
The RSM-CCD, employed for multiple regression analysis to optimize the culture conditions, elucidated the effects of different concentrations of saccharose (SAC) (0-7%) and phosphate (0.06-0.60 mM) in the MGV medium on the biosurfactant production (evaluated as E 24 ), which were analyzed in a set of 13 experiments designed by Minitab 21.0, and the predicted value and actual value are listed in Table 4. The emulsifying activity (E 24 ) was used as a response, and the obtained interaction was fitted as a quadratic model (Equation (1)) to predict the optimized conditions via ANOVA using Minitab 21. The derived equation can predict the E 24 as a function of SAC (%) and phosphate concentrations, P (mM), in the ranges investigated.
The response surface plot for the parameters and selection of the best conditions for the BS production (evaluated as E 24 ) as the response are shown in Figure 1. and phosphate (0.06-0.60 mM) in the MGV medium on the biosurfactant production (evaluated as E24), which were analyzed in a set of 13 experiments designed by Minitab 21.0, and the predicted value and actual value are listed in Table 4. The emulsifying activity (E24) was used as a response, and the obtained interaction was fitted as a quadratic model (Equation (1)) to predict the optimized conditions via ANOVA using Minitab 21. The response surface plot for the parameters and selection of the best conditions for the BS production (evaluated as E24) as the response are shown in Figure 1. According to ANOVA, the quadratic model of the present study was proven to be significant (p < 0.0001). The model's R 2 and F values were found to be 0.917 and 15.6, respectively, which further supports the significance of the model. Both saccharose and phosphate concentrations influenced the biosurfactant production. Overall, the predicted conditions for the highest E 24 (71%) were saccharose 5% and phosphate (0.06 mM) (p ≤ 0.05).
According to ANOVA, the quadratic model of the present study was proven to be significant (p < 0.0001). The model's R 2 and F values were found to be 0.917 and 15.6, respectively, which further supports the significance of the model. Both saccharose and phosphate concentrations influenced the biosurfactant production. Overall, the predicted conditions for the highest E24 (71%) were saccharose 5% and phosphate (0.06 mM) (p ≤ 0.05).

BS Characterization by ATR-FTIR
To better characterize the chemical structure of the BS B3-15, ATR-FTIR analysis was performed. The wavenumbers and their assignment to the different functional groups of the crude BS are reported in Table 5. Spectra obtained using ATR-FTIR analysis, used to compare the structural features of the crude BS produced in MGV or MGV-op, overlapped, and therefore, the spectrum of BS B3-15 produced in the MGV-op condition is shown in Figure 3.   Table 5. Spectra obtained using ATR-FTIR analysis, used to compare the structural features of the crude BS produced in MGV or MGV-op, overlapped, and therefore, the spectrum of BS B3-15 produced in the MGV-op condition is shown in Figure 3.  The peak observed at 3323 cm −1 was assigned to the OH-or NH-stretching mode. The peaks observed at 2967, 2924, and 2852 cm −1 and those at 1448 and 1386 cm −1 were attributed to the aliphatic (-CH3 and -CH2) stretching vibrations of lipids, indicating the presence of alkyl chains. The characteristics of the stretching frequencies of amides in the region 3300-3250 (Amide A) and the peaks at 1650 cm −1 (assigned to CO-N group) and at 1532 cm −1 (N-H bending of amide) were specific to surfactin-like lipopeptides.

BS B3-15 Surface Properties
To determine the ability of BS B3-15 to modify the surface properties of hydrophobic surfaces, the contact angle assay was performed. The contact angle of water on polystyrene decreased in the presence of BS B3-15 in a dose-dependent manner. At the highest BS concentration (1600 µg/mL), the contact angle was reduced from 89° to 47.03°, indicating that BS increased the interaction between the water and the hydrophobic surface due to the reduction in surface hydrophobicity ( Figure 4). The peak observed at 3323 cm −1 was assigned to the OH-or NH-stretching mode. The peaks observed at 2967, 2924, and 2852 cm −1 and those at 1448 and 1386 cm −1 were attributed to the aliphatic (-CH 3 and -CH 2 ) stretching vibrations of lipids, indicating the presence of alkyl chains. The characteristics of the stretching frequencies of amides in the region 3300-3250 (Amide A) and the peaks at 1650 cm −1 (assigned to CO-N group) and at 1532 cm −1 (N-H bending of amide) were specific to surfactin-like lipopeptides.

BS B3-15 Surface Properties
To determine the ability of BS B3-15 to modify the surface properties of hydrophobic surfaces, the contact angle assay was performed. The contact angle of water on polystyrene decreased in the presence of BS B3-15 in a dose-dependent manner. At the highest BS concentration (1600 µg/mL), the contact angle was reduced from 89 • to 47.03 • , indicating that BS increased the interaction between the water and the hydrophobic surface due to the reduction in surface hydrophobicity ( Figure 4).

Expression of Lichenysin Synthetase
The surfactin gene (srf A) was not detected in the DNA extracted from B. licheniformis B3-15, nor in that extracted from its closest phylogenetically related (99.87% similarity) B. licheniformis ATCC 9789. The lichenysin (lchAA) expression by B3-15 was evaluated in MGV and MGV-op over the time of incubation ( Figure 5). The gene expression was the highest after 24 h of incubation in MGV-op. However, the overexpression of the lchAA gene was observed after 12 h of incubation in MGV-op, rather than in the not-deprived phosphate condition (48 h). Figure 4. Surface properties, measured as contact angle (θ) values, with or without the BS B3-15 at different concentrations (0, 100, 200, 400, 800, and 1600 µg/mL). The bars represent the data mean ± SD for three replicates (n = 3). Statistical differences were evaluated using two-way ANOVA with Tukey's multiple comparisons test. Significantly different, * p ≤ 0.05 and ** p ≤ 0.01, compared with untreated controls. Different lowercase letters above the bar graph indicate significant statistical differences (p < 0.01).

Expression of Lichenysin Synthetase
The surfactin gene (srfA) was not detected in the DNA extracted from B. licheniformis B3-15, nor in that extracted from its closest phylogenetically related (99.87% similarity) B. licheniformis ATCC 9789. The lichenysin (lchAA) expression by B3-15 was evaluated in MGV and MGV-op over the time of incubation ( Figure 5). The gene expression was the highest after 24 h of incubation in MGV-op. However, the overexpression of the lchAA gene was observed after 12 h of incubation in MGV-op, rather than in the not-deprived phosphate condition (48 h).  The inhibitory effect on the biofilm formation of P. aeruginosa and S. aureus of the BS is dose-dependent ( Figure 6). BS B3-15 reduced the biofilm formation of P. aeruginosa (47.1%) more than S. aureus (35.9%) at the highest concentration (300 µg/mL). Significantly different ** p ≤ 0.01 compared with untreated controls. Different lowercase letters above the bar graph indicate significant statistical differences (p < 0.01).

Addition of BS B3-15on Polystyrene Surfaces with Increasing Concentrations
The inhibitory effect on the biofilm formation of P. aeruginosa and S. aureus of the BS is dose-dependent ( Figure 6). BS B3-15 reduced the biofilm formation of P. aeruginosa (47.1%) more than S. aureus (35.9%) at the highest concentration (300 µg/mL).   (50,100,200, and 300 µg/mL). The bars represent the mean ± standard deviation for six replicates (n = 6). * p ≤ 0.05 and ** p ≤ 0.01 show significant differences compared with untreated controls. Data on biofilm reduction (%) are reported in brackets.

BS B3-15 Addition on Polystyrene Surfaces at Different Times from the Inoculum
The BS B3-15 (300 µg/mL) was shown to inhibit the biofilm formation at different times after the inoculum (0, 2, 4 and 8 h) and after 24 h for S. aureus or 48 h for P. aeruginosa, when the biofilm was completely established, as shown in Figure 7. BS B3-15 added at 0 h and after 2 h strongly inhibited the adhesion and reversible attachment of P. aeruginosa (47.1 and 47.3% inhibition, respectively) and S. aureus (35.9 and 31.7% inhibition, respectively). BS B3-15 addition at 4 h and 8 h was also active with respect to the irreversible adhesion of P. aeruginosa (32.8 and 31.9% inhibition, respectively) and S. aureus (27.2 and 31.9% of inhibition, respectively). The BS was able to disrupt the preformed biofilms, being more efficient against S. aureus (47.2%) than P. aeruginosa (26.3%) (Figure 7), as also microscopically confirmed (Figure 8).  (300 µg/mL) at different bacterial growth times (T0, T2, T4, T8) and after T48 for P. aeruginosa and T24 for S. aureus, when the biofilms were completely established. The bars represent mean ± SD for six replicates (n = 6) * p ≤ 0.05 and ** p ≤ 0.01 show significant differences compared with untreated controls. Data on biofilm reduction (%) are reported in brackets. BS B3-15 added at 0 h and after 2 h strongly inhibited the adhesion and reversible attachment of P. aeruginosa (47.1 and 47.3% inhibition, respectively) and S. aureus (35.9 and 31.7% inhibition, respectively). BS B3-15 addition at 4 h and 8 h was also active with respect to the irreversible adhesion of P. aeruginosa (32.8 and 31.9% inhibition, respectively) and S. aureus (27.2 and 31.9% of inhibition, respectively). The BS was able to disrupt the preformed biofilms, being more efficient against S. aureus (47.2%) than P. aeruginosa (26.3%) (Figure 7), as also microscopically confirmed (Figure 8). BS B3-15 added at 0 h and after 2 h strongly inhibited the adhesion and reversible attachment of P. aeruginosa (47.1 and 47.3% inhibition, respectively) and S. aureus (35.9 and 31.7% inhibition, respectively). BS B3-15 addition at 4 h and 8 h was also active with respect to the irreversible adhesion of P. aeruginosa (32.8 and 31.9% inhibition, respectively) and S. aureus (27.2 and 31.9% of inhibition, respectively). The BS was able to disrupt the preformed biofilms, being more efficient against S. aureus (47.2%) than P. aeruginosa (26.3%) (Figure 7), as also microscopically confirmed (Figure 8).  As calculated by the imaging analysis (ImageJ 1.54d), in the presence of BS B3-15, the mean thickness of the preformed biofilm of P. aeruginosa was reduced by 24%, and that of S. aureus was reduced by 45.9%.

Antibacterial Activity
The BS (from 100 to 1000 µg/mL) did not influence the growth of P. aeruginosa or S. aureus ( Figure S1). No inhibition haloes were observed using the agar diffusion assay in the presence of BS B3-15, indicating that the biopolymer did not exert any antibacterial activity at the concentrations used.

Bioluminescent Assay
The evaluation of the possible interference of BS B3-15 on the bacterial quorum sensing and the toxicity effects were performed by bioluminescent inhibition assay [61]. The effects of BS B3-15 at different concentrations (from 0 to 1000 µg/mL) on the luminescence of V. harveyi G5 are reported in Figure S2. The luminescence (expressed as RLU) was constant in the presence of BS up to 500 µg/mL, and it decreased significantly in the presence of 750 µg/mL. The concentration of BS at which there was a 50% reduction in light emission was 966 ± 21.3 µg/mL (EC 50 ).

Effects of BS B3-15 Addition to Human Nasal Epithelial Cells
The BS B3-15 (from 50 to 300 µg/mL) added to HNEpC hindered the adhesion of P. aeruginosa and S. aureus (Figure 9) after 2 h of incubation at 37 • C. BS (300 µg/mL) reduced the adhesion of P. aeruginosa to more than one log scale, while the S. aureus was reduced to five log scales (Figure 9).
Microorganisms 2023, 11, x FOR PEER REVIEW 15 of 21 As calculated by the imaging analysis (ImageJ 1.54d), in the presence of BS B3-15, the mean thickness of the preformed biofilm of P. aeruginosa was reduced by 24%, and that of S. aureus was reduced by 45.9%.

Antibacterial Activity
The BS (from 100 to 1000 µg/mL) did not influence the growth of P. aeruginosa or S. aureus ( Figure S1). No inhibition haloes were observed using the agar diffusion assay in the presence of BS B3-15, indicating that the biopolymer did not exert any antibacterial activity at the concentrations used.

Bioluminescent Assay
The evaluation of the possible interference of BS B3-15 on the bacterial quorum sensing and the toxicity effects were performed by bioluminescent inhibition assay [61]. The effects of BS B3-15 at different concentrations (from 0 to 1000 µg/mL) on the luminescence of V. harveyi G5 are reported in Figure S2. The luminescence (expressed as RLU) was constant in the presence of BS up to 500 µg/mL, and it decreased significantly in the presence of 750 µg/mL. The concentration of BS at which there was a 50% reduction in light emission was 966 ± 21.3 µg/mL (EC50).

Effects of BS B3-15 Addition to Human Nasal Epithelial Cells
The BS B3-15 (from 50 to 300 µg/mL) added to HNEpC hindered the adhesion of P. aeruginosa and S. aureus (Figure 9) after 2 h of incubation at 37 °C. BS (300 µg/mL) reduced the adhesion of P. aeruginosa to more than one log scale, while the S. aureus was reduced to five log scales (Figure 9). The viability of HNEpC exposed to different BS B3-15 concentrations (from 50 to 500 µg/mL) after 24 h and 48 h is reported in Figure 10. The presence of crude BS at 300 µg/mL The viability of HNEpC exposed to different BS B3-15 concentrations (from 50 to 500 µg/mL) after 24 h and 48 h is reported in Figure 10. The presence of crude BS at 300 µg/mL did not significantly alter the viability of HNEpC after 24 h and 48 h of exposure compared to the control. At the highest concentration (500 µg/mL), the cell viability was reduced by 33%, indicating a cytotoxic effect of BS B3-15.  Figure 10. Viability of HNEpC exposed to different BS B3-15 concentrations (from 50 to 500 µg/mL) after 24 h or 48 h. Bars represent the data's mean ± SD for six replicates (n = 6).

Discussion
Lipopeptide surfactants (LPs), including iturin, surfactin, and lichenysins, exhibit powerful biological effects, such as antiviral and antimicrobial activities, due to their exceptional surface activity, reducing the surface and interfacial tension and the emulsifying properties [7]. LPs can promote or inhibit biofilm formation, depending upon the structure of the LP and the polarity of the cells and substrate [60]. Acting as pre-conditioning agents, LPs produced by Bacillus spp. were also reported to contrast with the bacterial adhesion to different surfaces, which represents a crucial step of bacterial biofilm formation due to their ability to decrease hydrophilic interactions between biotic or abiotic surfaces and bacteria [37,62]. These biosurfactant properties could be useful in controlling the microbial contamination by pathogens and their persistence as biofilms, which are a great concern in different contexts [33].
In this study, we evaluated the effects of the crude BS B3-15, produced by B. licheniformis B3-15, on the prevention and disruption of bacterial biofilm on polystyrene surfaces and human nasal cells. Since the biosynthesis of biosurfactants largely depends on nutritional factors [57,63,64], we first attempted to enhance the BS B3-15 yield for their largescale production, in optimized nutritional conditions of carbohydrates, phosphates, and nitrogen, as organic (as yeast and meat extracts) and inorganic (NH4SO4) sources. We previously reported that the copresence of peptone and saccharose supported the B. licheniformis B3-15 growth and gave the best results in terms of sufactin-like production [44].
Although similar values of B. licheniformis B3-15 growth were observed in the presence of glucose and saccharose, the highest E24 (60%) was registered at 5% saccharose. These data are according to Mendoza et al. [65], since molasses (rich in saccharose, fructose and glucose) performed with better indices than glucose and lactose in terms of B. subtilis DS03 biomass and higher crude biosurfactant production. Phosphate content greatly influenced both strain growth and BS B3-15 production. As predicted by RSM analysis, the lowest Figure 10. Viability of HNEpC exposed to different BS B3-15 concentrations (from 50 to 500 µg/mL) after 24 h or 48 h. Bars represent the data's mean ± SD for six replicates (n = 6).

Discussion
Lipopeptide surfactants (LPs), including iturin, surfactin, and lichenysins, exhibit powerful biological effects, such as antiviral and antimicrobial activities, due to their exceptional surface activity, reducing the surface and interfacial tension and the emulsifying properties [7]. LPs can promote or inhibit biofilm formation, depending upon the structure of the LP and the polarity of the cells and substrate [60]. Acting as pre-conditioning agents, LPs produced by Bacillus spp. were also reported to contrast with the bacterial adhesion to different surfaces, which represents a crucial step of bacterial biofilm formation due to their ability to decrease hydrophilic interactions between biotic or abiotic surfaces and bacteria [37,62]. These biosurfactant properties could be useful in controlling the microbial contamination by pathogens and their persistence as biofilms, which are a great concern in different contexts [33].
In this study, we evaluated the effects of the crude BS B3-15, produced by B. licheniformis B3-15, on the prevention and disruption of bacterial biofilm on polystyrene surfaces and human nasal cells. Since the biosynthesis of biosurfactants largely depends on nutritional factors [57,63,64], we first attempted to enhance the BS B3-15 yield for their large-scale production, in optimized nutritional conditions of carbohydrates, phosphates, and nitrogen, as organic (as yeast and meat extracts) and inorganic (NH 4 SO 4 ) sources. We previously reported that the copresence of peptone and saccharose supported the B. licheniformis B3-15 growth and gave the best results in terms of sufactin-like production [44]. Although similar values of B. licheniformis B3-15 growth were observed in the presence of glucose and saccharose, the highest E 24 (60%) was registered at 5% saccharose. These data are according to Mendoza et al. [65], since molasses (rich in saccharose, fructose and glucose) performed with better indices than glucose and lactose in terms of B. subtilis DS03 biomass and higher crude biosurfactant production. Phosphate content greatly influenced both strain growth and BS B3-15 production. As predicted by RSM analysis, the lowest phosphate concentration (0.06 mM) increased the crude BS B3-15 yield and its emulsifying activity (E 24 = 71%). BS B3-15 production was also verified via the detection and expression of genes related to the synthesis of lichenysin and surfactin at different incubation times. Lichenysin synthetase A gene (lchAA) was detected using PCR in strain B3-15, but not the surfactin gene (srf A), nor its closest phylogenetically related B. licheniformis ATCC 9789, which is reported to be unable to produce surfactin and iturin-A [66,67]. After 12 h and 24 h incubation in MGV-op conditions, lchAA gene expression levels were twofold greater than those of MGV, with the highest expression after 24 h. Interestingly, the early overexpression of the lchAA gene in MVG-op occurred during the exponential phase (12 h), with the consequent increase in the synthesis and lichenysin yield. This result suggests that, without increasing the strain biomass, the phosphate deprivation in MGV-op induced better indices of the BS-B3-15 yield (1.5 g/L), with the highest emulsified index (E 24 = 67%) compared to MGV. The emulsifying activity of both the cell-free supernatant and crude BS-B3-15 could compete with industrially manufactured surfactants, such as Triton-X-100 (74%) and sodium dodecyl sulfate (74.4%) [44]. To better characterize the partially purified BS B3-15 obtained under optimized conditions, the FTIR spectrum was analyzed. Although lichenysin and surfactin possess a similar lipopeptide structure and also a similar pattern [68], several differences were observed as shifts in specific peaks in the most representative bands of lipopeptide components. Specifically, the spectrum of BS B3-15 showed significant shifts at lower frequency of the characteristic bands attributed to the peptide structure (amide II and amide I), suggesting that the peptide component of BS B3-15 could possess a higher molecular weight than surfactin. Moreover, the shifts of peaks in the bands attributed to aliphatic chains (C-H stretching) of fatty acids indicated that the composition of the lipidic chains of BS B3-15 was different from that of surfactin.
The crude BS B3-15 was able to hinder the adhesion and the biofilm formation on abiotic surfaces without exerting any bacteriostatic or bactericidal activity, similarly to other bacterial antibiofilm polymers, such as the exopolysaccharide mannose-rich EPS B3-15, produced by the same B. licheniformis B3-15 using different cultural conditions [50]. The activity of EPS B3-15 and BS B3-15 were similar in reducing the biofilm formation of P. aeruginosa (52.7% and 47.1%, respectively) and S. aureus (35.9 and 32.3%, respectively) on polystyrene surfaces. Although the emulsifying activity of EPS B3-15 was low (E 24 = 37%) (unpublished data), its modes of action were related to the modifications of charges and the hydrophobicity of both abiotic (polystyrene and polyvinyl chloride surfaces) and bacterial surfaces, together with the modification in the expression patterns of genes involved in the early adhesion of P. aeruginosa and S. aureus. Unlike the EPS B3-15, the BS B3-15 also acted on the irreversible attachment and was able to disrupt the mature biofilms, being more efficient on S. aureus (47.2%) than P. aeruginosa (26.3%). Compared with other surfactants, such as the crude BS produced by B. subtilis DS03 [64] and the lipopeptide produced by B. licheniformis AL 1.1 [32], BS B3-15 was able to similarly disrupt the preformed biofilm of S. aureus on the polystyrene surface, but in contrast, the BS B3-15 was also able to partially disrupt the biofilm of P. aeruginosa. The biofilm-disruption effects of BS B3-15 may be explained by its ability to strongly reduce the interfacial tension between the polystyrene surface and the attached cells, as assessed by the reduction in the contact angle ( Figure 4) and therefore facilitating the biofilm removal. Since its addition at different concentrations did not affect the luminescence of Vibrio harveyi G5, BS B3-15 appears to not interfere with the quorum-sensing mechanism involved in the formation of bacterial biofilms.
In order to address its use in different medical applications, we evaluated the effects of the crude BS B3-15 on the adhesion of P. aeruginosa and S. aureus to human nasal epithelial cells (HNEpC), constituting the first barrier and one of the main targets of airborne bacterial infections. Although it is well known that human cells are sensitive to bacterial surfactants, the BS B3-15 did not show toxicity toward HNEpCs up to 300 µg/mL, probably due to its own peptide and lipidic structure. In contrast, lichenysins and surfactins from B. licheniformis B4094 and B4123 were reported to exert cytotoxic effects toward the tumoral Caco-2 human intestinal epithelial cells at very low concentrations (IC 50 16.6 and 23.5 µg/mL, respectively) [69]. BS B3-15 lichenysin (at 300 µg/mL) inhibited the adhesion of S. aureus (five-log scale) to human nasal cells more efficiently than P. aeruginosa (one-log scale). Conversely, the EPS B3-15 [50] was reported to be more effective in counteracting the adhesion of P. aeruginosa (five-log scale) to nasal cells than that of S. aureus (one-log scale). In future perspectives, the synergic action of BS B3-15 and EPS B3-15 could be evaluated to prospect their addition in a nasal spray to prevent infections of the upper respiratory tract. As assessed by the bioluminescence inhibition assay, which is also useful for detecting harmful effects of unknown substances on higher organisms in different environments [61,70], BS B3-15 could be considered safe, and therefore, its potential use as an antiadhesive could also be addressed in non-medical applications.

Conclusions
The marine, thermophilic B. licheniformis B3-15 represents a source of novel active biopolymers, with unique structural complexity and biocompatibility, that are useful in both environmental and human health.
The novel formulation of MGV optimized at low concentrations of phosphate induced the early production of the lichenysin-like lipopeptide, with better indices of BS-B3-15 yield and emulsified activity. Without exerting any antibacterial activity, BS B3-15 affected the early adhesion of P. aeruginosa and S. aureus on polystyrene surfaces, and it was also able to disrupt their preformed biofilms.
The BS B3-15 also inhibited the bacterial adhesion to HNEpC without interfering with cellular viability. This BS could be successfully utilized as a detergent and antiadhesive agent in industry (e.g., food, agriculture, cosmeceuticals) and for numerous medicine purposes, as nasal spray, or as a coating agent in functionalized devices (i.e., orthopedic and endotracheal devices, vascular and urinary catheters) to prevent the formation of and to remove preformed biofilms.
Supplementary Materials: The following supporting information can be downloaded at https: //www.mdpi.com/article/10.3390/microorganisms11071842/s1. Figure S1. Effects of EPS B3-15 addition at different concentrations (from 100 to 1000 µg/mL) on the growth (OD 600nm ) of P. aeruginosa (a) and S. aureus (b). Data represent mean ± SD for six replicates (n = 6). Figure S2. Effects of the presence of BS B3-15 at different concentrations on the luminescence of V. harveyi G5 after 15 min as a percentage of relative luminescence unit (RLU). Data represent mean ± SD for six replicates (n = 6).